VistaGen Therapeutics, Inc.
SYNTHESIS OF 4-CHLOROKYNURENINES AND INTERMEDIATES
Last updated:
Abstract:
The invention relates to an overall enantio-specific synthesis of 4-chlorokynurenine compounds, in particular L-4-chlorokynurenine, with improved yields. Large-scale syntheses are disclosed. The invention also relates to novel intermediates in the synthesis of L-4-chlorokynurenine.
Status:
Application
Type:
Utility
Filling date:
11 Feb 2019
Issue date:
9 Sep 2021